Skip to content

13F-HR filed by Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 30 holding rows worth $286,118,000.

Accession
0000950123-22-002404
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 30 entries on the cover page, a total value of $286,118,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $286,118,000 with VALUE read as thousands by filing date, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerFan Yu 028-20833

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATERA INC COM632307104Stock268,000$25,029,000thousands by filing date
ARVINAS INC04335A105COM230,000$18,892,000thousands by filing date
REPLIGEN CORP COM759916109Stock70,000$18,539,000thousands by filing date
ISOPLEXIS CORP465005106COM1,770,118$16,267,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM270,000$15,798,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM1,501,591$12,884,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM85,000$12,469,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM604,774$11,956,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM3,539,895$11,540,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM120,000$10,806,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock105,000$10,502,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock1,197,152$10,176,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock430,000$10,165,000thousands by filing date
LANTHEUS HLDGS INC516544103COM330,000$9,534,000thousands by filing date
SOMALOGIC INC83444K105COM800,000$9,312,000thousands by filing date
IVERIC BIO INC46583P102COM550,000$9,196,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM185,000$7,813,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM406,986$7,769,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM65,000$7,686,000thousands by filing date
NAUTILUS BIOTECHNOLOGY INC63909J108COM1,225,060$6,346,000thousands by filing date
SIGHT SCIENCES INC82657M105COMMON STOCK342,304$6,014,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM1,815,000$5,881,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock475,000$5,372,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM575,000$4,801,000thousands by filing date
RAPID MICRO BIOSYSTEMS INC75340L104CLASS A COM437,960$4,660,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM185,000$4,438,000thousands by filing date
MEDAVAIL HOLDINGS INC58406B103COM2,920,780$4,089,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM110,360$4,069,000thousands by filing date
CYTEIR THERAPEUTICS INC23284P103COMMON319,538$3,633,000thousands by filing date
MACROGENICS INC556099109COM30,000$482,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-002404this filing2022-02-14acceptance time not in the bulk data set